iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
10.14
+0.03 (0.30%)
Jun 24, 2025, 12:37 PM - Market open
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $388.10 million as of June 24, 2025. Its market cap has decreased by -40.15% in one year.
Market Cap
388.10M
Enterprise Value
-128.37M
1-Year Change
-40.15%
Ranking
Category
Stock Price
$10.14
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $388.10M, a decrease of -39.07%. That is a compound annual growth rate of -9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 386.95M | 37.91% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |